Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
c-Kit-IN-2 100mg	Inhibitors	Other	A18440-100 Adooq	100 mg	Login Compare	c-Kit-IN-2 100mg
GLUT4 activator 1 25mg	Inhibitors	Other	A18506-25 Adooq	25 mg	Login Compare	GLUT4 activator 1 25mg
GLUT4 activator 1 50mg	Inhibitors	Other	A18506-50 Adooq	50 mg	Login Compare	GLUT4 activator 1 50mg
GLUT4 activator 1 100mg	Inhibitors	Other	A18506-100 Adooq	100 mg	Login Compare	GLUT4 activator 1 100mg
FLT3-IN-4 25mg	Inhibitors	Other	A18509-25 Adooq	25 mg	Login Compare	FLT3-IN-4 25mg
FLT3-IN-4 50mg	Inhibitors	Other	A18509-50 Adooq	50 mg	Login Compare	FLT3-IN-4 50mg
FLT3-IN-4 100mg	Inhibitors	Other	A18509-100 Adooq	100 mg	Login Compare	FLT3-IN-4 100mg
FLT3-IN-4 500mg	Inhibitors	Other	A18509-500 Adooq	500 mg	Login Compare	FLT3-IN-4 500mg
FLT3-IN-4 10mM * 1mL in DMSO	Inhibitors	Other	A18509-10mM-D Adooq	10mM x 1mL in DMSO	Login Compare	FLT3-IN-4 10mM * 1mL in DMSO
PD-1-IN-22 10mg	Inhibitors	Other	A18434-10 Adooq	10 mg	Login Compare	PD-1-IN-22 10mg
Mcl-1-PUMA Modulator-8 1mg	Inhibitors	Other	A18369-1 Adooq	1 mg	Login Compare	Mcl-1-PUMA Modulator-8 1mg
Mcl-1-PUMA Modulator-8 25mg	Inhibitors	Other	A18369-25 Adooq	25 mg	Login Compare	Mcl-1-PUMA Modulator-8 25mg
Mcl-1-PUMA Modulator-8 100mg	Inhibitors	Other	A18369-100 Adooq	100 mg	Login Compare	Mcl-1-PUMA Modulator-8 100mg
Mcl-1 antagonist 1 25mg	Inhibitors	Other	A18375-25 Adooq	25 mg	Login Compare	Mcl-1 antagonist 1 25mg
MCL-1/BCL-2-IN-4 25mg	Inhibitors	Other	A18380-25 Adooq	25 mg	Login Compare	MCL-1/BCL-2-IN-4 25mg
MCL-1/BCL-2-IN-4 50mg	Inhibitors	Other	A18380-50 Adooq	50 mg	Login Compare	MCL-1/BCL-2-IN-4 50mg
MCL-1/BCL-2-IN-4 100mg	Inhibitors	Other	A18380-100 Adooq	100 mg	Login Compare	MCL-1/BCL-2-IN-4 100mg
MCL-1/BCL-2-IN-3 2mg	Inhibitors	Other	A18385-2 Adooq	2 mg	Login Compare	MCL-1/BCL-2-IN-3 2mg
MCL-1/BCL-2-IN-3 25mg	Inhibitors	Other	A18385-25 Adooq	25 mg	Login Compare	MCL-1/BCL-2-IN-3 25mg
MCL-1/BCL-2-IN-3 50mg	Inhibitors	Other	A18385-50 Adooq	50 mg	Login Compare	MCL-1/BCL-2-IN-3 50mg
MCL-1/BCL-2-IN-3 100mg	Inhibitors	Other	A18385-100 Adooq	100 mg	Login Compare	MCL-1/BCL-2-IN-3 100mg
MCL-1/BCL-2-IN-3 10mM * 1mL in DMSO	Inhibitors	Other	A18385-10mM-D Adooq	10mM x 1mL in DMSO	Login Compare	MCL-1/BCL-2-IN-3 10mM * 1mL in DMSO
c-Fms-IN-9 25mg	Inhibitors	Other	A18397-25 Adooq	25 mg	Login Compare	c-Fms-IN-9 25mg
c-Fms-IN-9 50mg	Inhibitors	Other	A18397-50 Adooq	50 mg	Login Compare	c-Fms-IN-9 50mg
c-Fms-IN-9 100mg	Inhibitors	Other	A18397-100 Adooq	100 mg	Login Compare	c-Fms-IN-9 100mg

Name Price

c-Kit-IN-2 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18440-100
Amount	100 mg
Available

GLUT4 activator 1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18506-25
Amount	25 mg
Available

GLUT4 activator 1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18506-50
Amount	50 mg
Available

GLUT4 activator 1 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18506-100
Amount	100 mg
Available

FLT3-IN-4 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18509-25
Amount	25 mg
Available

FLT3-IN-4 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18509-50
Amount	50 mg
Available

FLT3-IN-4 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18509-100
Amount	100 mg
Available

FLT3-IN-4 500mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18509-500
Amount	500 mg
Available

FLT3-IN-4 10mM * 1mL in DMSO

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18509-10mM-D
Amount	10mM x 1mL in DMSO
Available

PD-1-IN-22 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18434-10
Amount	10 mg
Available

Mcl-1-PUMA Modulator-8 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18369-1
Amount	1 mg
Available

Mcl-1-PUMA Modulator-8 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18369-25
Amount	25 mg
Available

Mcl-1-PUMA Modulator-8 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18369-100
Amount	100 mg
Available

Mcl-1 antagonist 1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18375-25
Amount	25 mg
Available

MCL-1/BCL-2-IN-4 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18380-25
Amount	25 mg
Available

MCL-1/BCL-2-IN-4 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18380-50
Amount	50 mg
Available

MCL-1/BCL-2-IN-4 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18380-100
Amount	100 mg
Available

MCL-1/BCL-2-IN-3 2mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18385-2
Amount	2 mg
Available

MCL-1/BCL-2-IN-3 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18385-25
Amount	25 mg
Available

MCL-1/BCL-2-IN-3 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18385-50
Amount	50 mg
Available

MCL-1/BCL-2-IN-3 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18385-100
Amount	100 mg
Available

MCL-1/BCL-2-IN-3 10mM * 1mL in DMSO

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18385-10mM-D
Amount	10mM x 1mL in DMSO
Available

c-Fms-IN-9 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18397-25
Amount	25 mg
Available

c-Fms-IN-9 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18397-50
Amount	50 mg
Available

c-Fms-IN-9 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18397-100
Amount	100 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk